These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20558855)

  • 21. [Veno-occlusive disease of the liver].
    Rybicka M; Krysiak R; Okopień B
    Wiad Lek; 2009; 62(1):42-51. PubMed ID: 19817257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease.
    Zhuge YZ; Wang Y; Zhang F; Zhu CK; Zhang W; Zhang M; He Q; Yang J; He J; Chen J; Zou XP
    Liver Int; 2018 Oct; 38(10):1867-1874. PubMed ID: 29297975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma protein C is a useful clinical marker for hepatic veno-occlusive disease (VOD) in stem cell transplantation.
    Iguchi A; Kobayashi R; Kaneda M; Kobayashi K
    Pediatr Blood Cancer; 2010 Mar; 54(3):437-43. PubMed ID: 19911420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study.
    Tanikawa S; Mori S; Ohhashi K; Akiyama H; Sasaki T; Kaku H; Hiruma K; Matsunaga T; Morita T; Sakamaki H
    Bone Marrow Transplant; 2000 Oct; 26(8):881-6. PubMed ID: 11081389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea.
    Roulet M; Laurini R; Rivier L; Calame A
    J Pediatr; 1988 Mar; 112(3):433-6. PubMed ID: 3346784
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatic veno-occlusive disease induced by Chinese medicinal herbs.
    Mejías Manzano MLÁ; Giráldez Gallego Á; Serrano Jiménez M
    Rev Esp Enferm Dig; 2017 Nov; 109(11):804. PubMed ID: 29032695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.
    Yang M; Ruan J; Gao H; Li N; Ma J; Xue J; Ye Y; Fu PP; Wang J; Lin G
    Arch Toxicol; 2017 Dec; 91(12):3913-3925. PubMed ID: 28620673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment with danhong injection for hepatic veno-occlusive disease.
    Yao JY; Zhi M; Cao WT; Huang Y; Li CJ
    Hepatogastroenterology; 2011; 58(107-108):992-5. PubMed ID: 21830430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Budd-Chiari syndrome and hepatic veno-occlusive disease. Recognition and treatment.
    McDermott WV; Ridker PM
    Arch Surg; 1990 Apr; 125(4):525-7. PubMed ID: 2322120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic Resonance Imaging Findings in Patients With Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome.
    Li X; Yang X; Xu D; Li Q; Kong X; Lu Z; Bai T; Xu K; Ye J; Song Y
    Clin Gastroenterol Hepatol; 2017 Jun; 15(6):955-957. PubMed ID: 28126425
    [No Abstract]   [Full Text] [Related]  

  • 31. Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
    Zhuge Y; Liu Y; Xie W; Zou X; Xu J; Wang J;
    J Gastroenterol Hepatol; 2019 Apr; 34(4):634-642. PubMed ID: 30669184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GC/MS identification of toxic pyrrolizidine alkaloids in traditional remedies given to two sets of twins.
    Conradie J; Stewart MJ; Steenkamp V
    Ann Clin Biochem; 2005 Mar; 42(Pt 2):141-4. PubMed ID: 15829125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.
    Hasegawa S; Horibe K; Kawabe T; Kato K; Kojima S; Matsuyama T; Hirabayashi N
    Bone Marrow Transplant; 1998 Dec; 22(12):1191-7. PubMed ID: 9894723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyrrolizidine alkaloid-induced alterations of prostanoid synthesis in human endothelial cells.
    Ebmeyer J; Behrend J; Lorenz M; Günther G; Reif R; Hengstler JG; Braeuning A; Lampen A; Hessel-Pras S
    Chem Biol Interact; 2019 Jan; 298():104-111. PubMed ID: 30465738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herbal medicines and veno-occlusive disease in India.
    Datta DV; Khuroo MS; Mattocks AR; Aikat BK; Chhuttani PN
    Postgrad Med J; 1978 Aug; 54(634):511-5. PubMed ID: 733681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical analysis of hepatic veno-occlusive disease induced by Sedum aizoon].
    Wu GL; Yu GY; Chen J
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2402-4. PubMed ID: 19157138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic veno-occlusive disease and drinking of herbal teas.
    Sommer M
    J Pediatr; 1989 Oct; 115(4):659-60. PubMed ID: 2610755
    [No Abstract]   [Full Text] [Related]  

  • 38. [Veno-occlusive liver disease induced by Senecio vulgaris toxicity].
    Vilar JH; García M; Cabrera P
    Gastroenterol Hepatol; 2000; 23(6):285-6. PubMed ID: 15324624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human embryotoxicity of pyrrolizidine-containing drugs.
    Huxtable RJ
    Hepatology; 1989 Mar; 9(3):510-1. PubMed ID: 2921005
    [No Abstract]   [Full Text] [Related]  

  • 40. Ursodiol to prevent hepatic venoocclusive disease.
    Comcowich SA; Spitzer TR; Tsunoda SM
    Ann Pharmacother; 1997 Oct; 31(10):1249-52. PubMed ID: 9337452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.